Publications by authors named "Eiko Toichi"

Claim this Profile
S
Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial.
Takashi Nomura, Eriko Sumi, Gyohei Egawa, Saeko Nakajima, Eiko Toichi

JID Innov· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged acute generalized exanthematous pustulosis and atypical target-like lesions induced by hydroxychloroquine.
Hikari Otake-Irie, Saeko Nakajima, Natsuko Okamoto, Eiko Toichi, Takashi Nomura

J Dermatol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial.
Takashi Nomura, Eriko Sumi, Gyohei Egawa, Saeko Nakajima, Eiko Toichi

Trials· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case of multiple disseminated cutaneous lobular capillary hemangioma that developed while taking oral contraceptive pills.
Shunya Usui, Toshiaki Kogame, Mami Shibuya, Natsuko Okamoto, Eiko Toichi

J Dermatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Mild Case of Adult-Onset Keratosis Lichenoides Chronica Successfully Treated with Narrow-Band UVB Monotherapy.
Takashi Nomura, Eiko Toichi, Yoshiki Miyachi, Kenji Kabashima

Case Rep Dermatol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circumscribed palmo-plantar hypokeratosis: a disease with two subtypes.
Miki Tanioka, Aya Miyagawa-Hayashino, Toshiaki Manabe, Eiko Toichi, Yoshiki Miyachi

J Invest Dermatol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skin-infiltrating monocytes/macrophages migrate to draining lymph nodes and produce IL-10 after contact sensitizer exposure to UV-irradiated skin.
Eiko Toichi, Kurt Q Lu, Alan R Swick, Thomas S McCormick, Kevin D Cooper

J Invest Dermatol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, double-blind, placebo-controlled study evaluating single subcutaneous administrations of a human interleukin-12/23 monoclonal antibody in subjects with plaque psoriasis.
Alice B Gottlieb, Kevin D Cooper, Thomas S McCormick, Eiko Toichi, Daniel E Everitt

Curr Med Res Opin· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.
Eiko Toichi, Gisela Torres, Thomas S McCormick, Timothy Chang, Mary Ann Mascelli

J Immunol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.
Hideaki Sugiyama, Rolland Gyulai, Eiko Toichi, Edina Garaczi, Shinji Shimada

J Immunol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis.
Catharine L Kauffman, Nancy Aria, Eiko Toichi, Thomas S McCormick, Kevin D Cooper

J Invest Dermatol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell surface and cytokine phenotypes of skin immunocompetent cells involved in ultraviolet-induced immunosuppression.
Eiko Toichi, Thomas S McCormick, Kevin D Cooper

Methods· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis